The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
about
Evolving clinical phenotypes in HIV-associated neurocognitive disordersGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderThe Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewHIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional studyDefining cognitive impairment in people-living-with-HIV: the POPPY study.Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power.HIV-associated neurocognitive disorder.Neurocognitive function in HIV-infected patients: comparison of two methods to define impairmentAsymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative menNeuropsychiatric Effects of HIV Antiviral Medications.A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Controversies in HIV-associated neurocognitive disordersBiomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.Parkinson's disease mild cognitive impairment: application and validation of the criteria.A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients.Prevalence and Correlates of HIV-Associated Neurocognitive Disorders (HAND) in Northwestern Nigeria.Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive ImpairmentValidation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapyAntiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIVCognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.Health-Related Decision-Making in HIV Disease.Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial.Screening for Neurocognitive Impairment in HIV Individuals: The Utility of the Montreal Cognitive Assessment Test.Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunities.Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.An evidence-based approach to the creation of normative data: base rates of impaired scores within a brief neuropsychological battery argue for age corrections, but against corrections for medical conditions.Interventions for Neurocognitive Dysfunction.A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.Effect of Retrieval Practice on Short-Term and Long-Term Retention in HIV+ Individuals.The Role of HIV Infection in Neurologic Injury.
P2860
Q26859192-C1BD400B-3B9B-4025-9FF7-7A6A82D6D6AAQ26865707-00ED95E9-777F-4822-A2C2-C199ECF83F5CQ28066725-15ED5A16-C779-489E-AE72-C6A8320B5E92Q28539550-740C83E1-DAC4-45F2-98D7-7D082792E810Q30826784-2CBBA919-46B2-45C4-A5C9-618CE07DC57FQ33603955-A967E7B0-9E22-4757-8B5C-86A7ED82BCBDQ33939729-A7058A13-E281-409F-A25F-3F76BA2CEEC3Q33982015-0D052139-FC0C-40D5-AEC7-13E37F4A9470Q33987146-2BA501FB-0770-4974-B5E3-F0D7B43D5692Q34113118-4D9258CC-598C-4646-9CF7-14A3661B14FEQ34243885-CE4F57DC-EDD8-4D2C-9A75-43996F45C766Q34537705-20557C4F-1199-4486-8151-D752ACDA060CQ34685180-1FE4C9BB-53D3-4AF4-8C84-77FD36D37003Q34769218-CBC12A90-5DA6-4D0F-A415-3C29C3B74287Q34776835-784CD2C4-B9CC-420E-91F6-353E6FBCF608Q35037015-D5FD271A-A02C-42AF-BEEE-81674AD71C5DQ35093695-F9A85FEA-ECD3-4F0F-AEC4-C32EE3A873F0Q35220349-2E055F4A-6530-4C8A-AB63-CFEDA9A85E4FQ35233945-DBDD4356-4A52-45EF-BE11-7466ADD5DF17Q35648919-8458AE97-3D1F-4E62-9A65-764DD30949FDQ35878267-882612CD-F7E4-4441-8887-C184FB5F9799Q35988117-3A2151F5-47A9-4C37-8ED7-7A4CAD6F4575Q36050420-55ED9CCF-F6DD-4074-887D-D4728476C552Q36228243-284C7511-ABB3-45D6-90CC-2FF0FEAF0CCDQ36425853-019D487A-00A0-4855-83FA-8AC680D4BCE6Q36661109-339C1F17-CE0B-49A2-8543-0FCF58DEADFEQ36712281-C9457658-F6C3-4083-B29A-E1AABEDE58F7Q36931956-1BCC34F4-BFC2-4D7A-A67F-FEC6AD6D10A4Q37055030-8B969EBD-6C14-46D3-8D0E-6F90A8CA82B4Q37096724-F403E16C-54BA-470E-9139-A5229A84E0C1Q37340889-8CE6E483-E56A-4408-81FE-AED393B4BA81Q38122719-D737086E-1D17-4D52-AD31-D3C3A80043F7Q38679995-91BCA4A6-6635-4D65-9DD8-FB424F629132Q38692560-7A61CA07-D3DB-4A29-91E2-125AF1B33407Q38767396-03798F39-CC00-46A9-9014-C37C450ED25AQ38767650-F761827B-40B8-4B76-A8CF-054040A0270BQ38871573-19C33C69-5050-40EB-89B6-AF7F0721EEB7Q38886999-E98A1B1E-AC31-47BD-92F8-FE8E541C149EQ39032359-D98A1183-726E-4830-84E7-55FEBE0A3774Q39224160-A736F89D-D581-4DD4-B7B3-F9E59AA29B9B
P2860
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The definition of HIV-associat ...... stimating the real prevalence?
@ast
The definition of HIV-associat ...... stimating the real prevalence?
@en
The definition of HIV-associat ...... stimating the real prevalence?
@nl
type
label
The definition of HIV-associat ...... stimating the real prevalence?
@ast
The definition of HIV-associat ...... stimating the real prevalence?
@en
The definition of HIV-associat ...... stimating the real prevalence?
@nl
prefLabel
The definition of HIV-associat ...... stimating the real prevalence?
@ast
The definition of HIV-associat ...... stimating the real prevalence?
@en
The definition of HIV-associat ...... stimating the real prevalence?
@nl
P2860
P356
P1476
The definition of HIV-associat ...... stimating the real prevalence?
@en
P2093
Magnus Gisslén
Richard W Price
P2860
P2888
P356
10.1186/1471-2334-11-356
P577
2011-12-28T00:00:00Z
P5875
P6179
1033831980